Table 1

Characteristics of included studies

No	Author	Year	Type of manuscript	Number of patients	Patient population	Mean age (year)	Man, %	TAPSE EF (mm)	TAPSE correlation coefficient	P value for TAPSE	FAC EF (%)	FAC correlation coefficient	P value	CMR RVEF (%)
1.	Anavekar et al	2007	Paper	36	Patient undergoing assessment of ischaemia or viability	59±12	63	NA	0.17	<0.30	NA	0.8	<0.0001	55±8.9
2.	Arnould et al	2009	Paper	19	Mixed population with EF ≤45%	NA	NA	18.8±5.7	0.472	0.006	33±11	0.684	0.000	29.53±10.29
2.	Arnould et al	2009	Paper	13	Mixed population with EF >45%	NA	NA	21.2±5.1	0.472	0.006	47±8	0.684	0.000	55.6±5.4
3.	Chen et al	2011	Abstract	60	All clinical patients referred for CMR also underwent echocardiography	45	60	NA	0.48	0.01	NA	0.56	<0.001	50%
4.	Focardi et al	2015	Paper	63	Mixed population with RVEF ≤45%	46±17	49	18.2±4.4	0.45	0.01	42.2±11	0.77	<0.0001	40.1±4.8
4.	Focardi et al	2015	Paper	63	Mixed population with RVEF> 45%	43±17	48	23.2±4.6	NA	NA	55.4±11	NA	NA	58.8±8.2
5.	Freed et al	2012	Abstract	25	PAH	NA	NA	NA	0.47	NA	NA	0.63	NA	35±14
6.	Grover et al	2011	Abstract	90	Mixed population	61	NA	NA	0.65	<0.001	NA	0.53	0.002	NA
7.	Lemarie et al	2015	Paper	135	AMI	55±11	87	21.8±4.5	0.267	0.002	43.8±9.6	0.368	<0.0001	54.8±6.2
8.	Li et al	2015	Paper	32	CTEPH	55±12	53	13.74±2.29	0.451	0.22	29.9±9.01	0.423	0.022	39±9
9.	Maceira Gonzales et al	2010	Abstract	40	Mixed population	NA	NA	NA	0.80	>0.001	NA	0.76	>0.001	NA
10.	Pavlicek et al	2011	Paper	129	RVEF ≥50%	44±19	70	20±6	0.34	<0.0001	41±13	0.47	<0.0001	61±7
				67	RVEF >30%–49%	41±18	66	17±6			33±11			44±3
				27	RVEF ≤30%	53±20	85	13±5			23±8			28±2
11.	Renard et al	2014	Abstract	61	PH	57±16	47	NA	0.48	NA	NA	0.51	NA	NA
12.	Sato et al	2012	Paper	37	PAH	53±15	30	19±4	0.86	NA	31±17	0.4	NA	38±11
13.	Shiran et al	2O14	Paper	40	PAH	42±12	15	NA	0.8	<0.001	NA	0.87	<0.001	35±15
14.	Spruijt et al	2017	Paper	96	PH	53±16	28	18.8±4	0.485	NA	35.8±11.4	0.753	NA	41.4±15.2
15.	Takemoto et al	2015	Abstract	142	NA	55±18	54	NA	0.22	0.0121	NA	0.596	<0.0001	NA
16.	Yang et al	2013	Paper	30	PAH	30±10	20	16.3±2.7	0.440	0.015	28.9±7.0	0.416	0.022	27±12
17.	Zhou et al	2015	Abstract	125	NA	55±16	51	19.6±5.4	0.12	0.4	42.9±9.1	0.43	0.003	53.6±11.6

CMR, cardiac magnetic resonance; CTEPH, chronic thromboembolic pulmonary hypertension; EF, ejection fraction; FAC, fractional area change; PAH, pulmonary arterial hypertension; PH, pulmonary hypertension; RVEF, right ventricular ejection fraction; TAPSE, tricuspid annular plane systolic excursion.